蚌埠地区89例COVID-19肺炎病例分析  

Analysis of Covid-19 Pneumonia Cases in Bengbu Area

作　　者：李薇薇 钱峰 孙景巍[1] Li Weiwei;Qian Feng;Sun Jingwei(Bengbu First People's Hospital,Bengbu 233000,China)

机构地区：[1]蚌埠市第一人民医院,安徽蚌埠233000

出　　处：《哈尔滨医药》2021年第3期42-44,共3页Harbin Medical Journal

摘　　要：目的分析蚌埠地区89例COVID-19患者的临床数据以判断患者病情严重程度。方法选取2020年2月蚌埠市传染病医院收治的89例普通型新型冠状病毒感染肺炎确诊患者作为确诊病例组作回顾性研究,将患者分为轻症和重症两组,分析两组患者住院期间的症状、实验室检查、胸部CT结果。结果轻症与重症患者年龄相比较低,临床症状食欲减退及呼吸困难对比有统计学意义(P<0.05);轻症患者的白细胞计数、中性粒细胞计数、淋巴细胞计数、白蛋白、胱抑素C、乳酸脱氢酶、微球蛋白与重症患者相比较,差异有统计学意义(P<0.05)。结论 COVID-19患者相关实验室检测及临床症状较为典型,可以作为轻症患者病情进展的相关指标。Objective To analyze the clinical data of 89 COVID-19 patients in Bengbu area to determine the severity of the patient’s condition.Methods A retrospective study was conducted on 89 patients with common type of novel coronavirus infection pneumonia admitted to Bengbu Infectious Diseases Hospital in February 2020 as the confirmed case group.The patients were divided into mild and severe two groups,and the two groups were hospitalized Symptoms,laboratory examinations,chest CT Results during the period.Results Mild and severe patients were relatively younger,and the clinical symptoms of severe loss of appetite and dyspnea were different,which was statistically significant(P<0.05);the white blood cell count,neutrophil count,and lymphocyte count of mild patients,Albumin,cystatin C,lactate dehydrogenase,microglobulin compared with severe patients,the difference was statistically significant(P<0.05).Conclusion The relevant laboratory tests and clinical symptoms of COVID-19 patients are more typical,which can be used as relevant indicators for the progress of mild patients.

关 键 词：COVID-19 临床症状 胱抑素C 乳酸脱氢酶 白蛋白 微球蛋白 

分 类 号：R563.1[医药卫生—呼吸系统]